HEADER HYDROLASE, TRANSFERASE 09-JAN-15 4XJS TITLE HUMAN CD38 COMPLEXED WITH INHIBITOR 1 [6-FLUORO-2-METHYL-4-[(2,3,6- TITLE 2 TRICHLOROBENZYL)AMINO]QUINOLINE-8-CARBOXAMIDE] COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADP-RIBOSYL CYCLASE/CYCLIC ADP-RIBOSE HYDROLASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: 2'-PHOSPHO-ADP-RIBOSYL CYCLASE,2'-PHOSPHO-ADP-RIBOSYL COMPND 5 CYCLASE/2'-PHOSPHO-CYCLIC-ADP-RIBOSE TRANSFERASE,2'-PHOSPHO-CYCLIC- COMPND 6 ADP-RIBOSE TRANSFERASE,ADP-RIBOSYL CYCLASE 1,ADPRC 1,CYCLIC ADP- COMPND 7 RIBOSE HYDROLASE 1,CADPR HYDROLASE 1,T10; COMPND 8 EC: 3.2.2.6,2.4.99.20; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CD38; SOURCE 6 EXPRESSION_SYSTEM: PICHIA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4919 KEYWDS CD38, HYDROLASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR L.M.SHEWCHUK,D.DEATON,E.STEWART REVDAT 5 27-SEP-23 4XJS 1 HETSYN LINK REVDAT 4 29-JUL-20 4XJS 1 JRNL REMARK LINK SITE REVDAT 4 2 1 ATOM REVDAT 3 23-SEP-15 4XJS 1 JRNL REVDAT 2 09-SEP-15 4XJS 1 JRNL REVDAT 1 26-AUG-15 4XJS 0 JRNL AUTH J.D.BECHERER,E.E.BOROS,T.Y.CARPENTER,D.J.COWAN,D.N.DEATON, JRNL AUTH 2 C.D.HAFFNER,M.R.JEUNE,I.W.KALDOR,J.C.POOLE,F.PREUGSCHAT, JRNL AUTH 3 T.R.RHEAULT,C.A.SCHULTE,B.G.SHEARER,T.W.SHEARER, JRNL AUTH 4 L.M.SHEWCHUK,T.L.SMALLEY,E.L.STEWART,J.D.STUART,J.C.ULRICH JRNL TITL DISCOVERY OF 4-AMINO-8-QUINOLINE CARBOXAMIDES AS NOVEL, JRNL TITL 2 SUBMICROMOLAR INHIBITORS OF NAD-HYDROLYZING ENZYME CD38. JRNL REF J.MED.CHEM. V. 58 7021 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 26267483 JRNL DOI 10.1021/ACS.JMEDCHEM.5B00992 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 5790 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 293 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 395 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.52 REMARK 3 BIN R VALUE (WORKING SET) : 0.2630 REMARK 3 BIN FREE R VALUE SET COUNT : 23 REMARK 3 BIN FREE R VALUE : 0.3350 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1886 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 39 REMARK 3 SOLVENT ATOMS : 23 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.01000 REMARK 3 B22 (A**2) : -0.12000 REMARK 3 B33 (A**2) : 0.11000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.439 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.351 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 36.526 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.896 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1999 ; 0.009 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 1785 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2730 ; 1.239 ; 1.953 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4121 ; 0.792 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 243 ; 5.427 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 88 ;39.038 ;25.227 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 324 ;14.175 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 5 ;15.953 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 299 ; 0.065 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2237 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 453 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 960 ; 1.202 ; 3.341 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 959 ; 1.191 ; 3.338 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1198 ; 1.961 ; 5.004 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 300 REMARK 3 ORIGIN FOR THE GROUP (A): -7.1410 -14.8440 15.1420 REMARK 3 T TENSOR REMARK 3 T11: 0.1132 T22: 0.0917 REMARK 3 T33: 0.1935 T12: -0.0313 REMARK 3 T13: -0.0416 T23: 0.0075 REMARK 3 L TENSOR REMARK 3 L11: 1.3648 L22: 1.8582 REMARK 3 L33: 3.5303 L12: -0.5353 REMARK 3 L13: -1.5292 L23: 0.3110 REMARK 3 S TENSOR REMARK 3 S11: -0.1248 S12: 0.0034 S13: 0.0158 REMARK 3 S21: 0.1817 S22: 0.0566 S23: 0.2447 REMARK 3 S31: 0.1080 S32: -0.1512 S33: 0.0682 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 4XJS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JAN-15. REMARK 100 THE DEPOSITION ID IS D_1000205780. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JAN-11 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 5790 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 34.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 29.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.87 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 7.00 REMARK 200 R MERGE FOR SHELL (I) : 0.59000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 1YH3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN CONCENTRATION WAS 7MGS/ML. REMARK 280 CRYSTALS WERE GROWN FROM 23% PEG3350, 0.1MM BISTRISPROPANE AT 22 REMARK 280 DEG C (2+2UL DROPS OVER A 500UL WELL). CRYSTALS WERE SOAKED WITH REMARK 280 5MM INHIBITOR FOR 24 HOURS PRIOR TO DATA COLLECTION. CRYSTALS REMARK 280 WERE FLASH FROZEN IN PFO., PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.14900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.41600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.21200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 36.41600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.14900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.21200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 39 REMARK 465 GLY A 40 REMARK 465 LYS A 41 REMARK 465 ASN A 42 REMARK 465 PRO A 43 REMARK 465 GLU A 44 REMARK 465 ASP A 45 REMARK 465 GLY A 246 REMARK 465 ARG A 247 REMARK 465 GLU A 248 REMARK 465 ASP A 249 REMARK 465 LYS A 289 REMARK 465 ASN A 290 REMARK 465 PRO A 291 REMARK 465 GLU A 292 REMARK 465 ASP A 293 REMARK 465 SER A 294 REMARK 465 SER A 295 REMARK 465 CYS A 296 REMARK 465 THR A 297 REMARK 465 SER A 298 REMARK 465 GLU A 299 REMARK 465 ILE A 300 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 47 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 58 NE CZ NH1 NH2 REMARK 470 ARG A 78 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 111 CD CE NZ REMARK 470 ARG A 127 NE CZ NH1 NH2 REMARK 470 GLN A 139 CG CD OE1 NE2 REMARK 470 ARG A 140 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 177 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 194 CZ NH1 NH2 REMARK 470 SER A 213 OG REMARK 470 LYS A 218 CE NZ REMARK 470 LYS A 260 CE NZ REMARK 470 LYS A 276 CE NZ REMARK 470 ARG A 280 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 282 CG OD1 OD2 REMARK 470 GLN A 286 CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 100 51.40 -110.08 REMARK 500 ARG A 127 -35.37 69.23 REMARK 500 VAL A 138 -69.66 -102.62 REMARK 500 ARG A 140 -11.60 81.45 REMARK 500 ALA A 164 -25.09 82.56 REMARK 500 ASP A 179 -59.79 -121.49 REMARK 500 ASN A 182 49.83 -88.42 REMARK 500 ASP A 202 -113.84 60.88 REMARK 500 CYS A 287 1.56 -67.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4XJT RELATED DB: PDB DBREF 4XJS A 46 300 UNP P28907 CD38_HUMAN 46 300 SEQADV 4XJS ARG A 39 UNP P28907 EXPRESSION TAG SEQADV 4XJS GLY A 40 UNP P28907 EXPRESSION TAG SEQADV 4XJS LYS A 41 UNP P28907 EXPRESSION TAG SEQADV 4XJS ASN A 42 UNP P28907 EXPRESSION TAG SEQADV 4XJS PRO A 43 UNP P28907 EXPRESSION TAG SEQADV 4XJS GLU A 44 UNP P28907 EXPRESSION TAG SEQADV 4XJS ASP A 45 UNP P28907 EXPRESSION TAG SEQADV 4XJS ASP A 100 UNP P28907 ASN 100 ENGINEERED MUTATION SEQADV 4XJS ALA A 164 UNP P28907 ASN 164 ENGINEERED MUTATION SEQADV 4XJS ASP A 209 UNP P28907 ASN 209 ENGINEERED MUTATION SEQADV 4XJS ASP A 219 UNP P28907 ASN 219 ENGINEERED MUTATION SEQRES 1 A 262 ARG GLY LYS ASN PRO GLU ASP TRP ARG GLN GLN TRP SER SEQRES 2 A 262 GLY PRO GLY THR THR LYS ARG PHE PRO GLU THR VAL LEU SEQRES 3 A 262 ALA ARG CYS VAL LYS TYR THR GLU ILE HIS PRO GLU MET SEQRES 4 A 262 ARG HIS VAL ASP CYS GLN SER VAL TRP ASP ALA PHE LYS SEQRES 5 A 262 GLY ALA PHE ILE SER LYS HIS PRO CYS ASP ILE THR GLU SEQRES 6 A 262 GLU ASP TYR GLN PRO LEU MET LYS LEU GLY THR GLN THR SEQRES 7 A 262 VAL PRO CYS ASN LYS ILE LEU LEU TRP SER ARG ILE LYS SEQRES 8 A 262 ASP LEU ALA HIS GLN PHE THR GLN VAL GLN ARG ASP MET SEQRES 9 A 262 PHE THR LEU GLU ASP THR LEU LEU GLY TYR LEU ALA ASP SEQRES 10 A 262 ASP LEU THR TRP CYS GLY GLU PHE ALA THR SER LYS ILE SEQRES 11 A 262 ASN TYR GLN SER CYS PRO ASP TRP ARG LYS ASP CYS SER SEQRES 12 A 262 ASN ASN PRO VAL SER VAL PHE TRP LYS THR VAL SER ARG SEQRES 13 A 262 ARG PHE ALA GLU ALA ALA CYS ASP VAL VAL HIS VAL MET SEQRES 14 A 262 LEU ASP GLY SER ARG SER LYS ILE PHE ASP LYS ASP SER SEQRES 15 A 262 THR PHE GLY SER VAL GLU VAL HIS ASN LEU GLN PRO GLU SEQRES 16 A 262 LYS VAL GLN THR LEU GLU ALA TRP VAL ILE HIS GLY GLY SEQRES 17 A 262 ARG GLU ASP SER ARG ASP LEU CYS GLN ASP PRO THR ILE SEQRES 18 A 262 LYS GLU LEU GLU SER ILE ILE SER LYS ARG ASN ILE GLN SEQRES 19 A 262 PHE SER CYS LYS ASN ILE TYR ARG PRO ASP LYS PHE LEU SEQRES 20 A 262 GLN CYS VAL LYS ASN PRO GLU ASP SER SER CYS THR SER SEQRES 21 A 262 GLU ILE HET 733 A 401 26 HET HSX A 402 13 HETNAM 733 6-FLUORO-2-METHYL-4-[(2,3,6-TRICHLOROBENZYL) HETNAM 2 733 AMINO]QUINOLINE-8-CARBOXAMIDE HETNAM HSX 5-O-PHOSPHONO-ALPHA-D-RIBOFURANOSE HETSYN HSX 5-O-PHOSPHONO-ALPHA-D-RIBOSE; 5-O-PHOSPHONO-D-RIBOSE; HETSYN 2 HSX 5-O-PHOSPHONO-RIBOSE FORMUL 2 733 C18 H13 CL3 F N3 O FORMUL 3 HSX C5 H11 O8 P FORMUL 4 HOH *23(H2 O) HELIX 1 AA1 ARG A 58 HIS A 74 1 17 HELIX 2 AA2 PRO A 75 ARG A 78 5 4 HELIX 3 AA3 ASP A 81 ILE A 94 1 14 HELIX 4 AA4 THR A 102 GLY A 113 1 12 HELIX 5 AA5 PRO A 118 LYS A 121 5 4 HELIX 6 AA6 ILE A 128 GLN A 139 1 12 HELIX 7 AA7 THR A 144 ASP A 147 5 4 HELIX 8 AA8 THR A 148 ASP A 155 1 8 HELIX 9 AA9 ASN A 183 ALA A 200 1 18 HELIX 10 AB1 SER A 220 VAL A 225 1 6 HELIX 11 AB2 GLU A 226 LEU A 230 5 5 HELIX 12 AB3 ASP A 252 GLN A 255 5 4 HELIX 13 AB4 ASP A 256 LYS A 268 1 13 HELIX 14 AB5 ARG A 280 VAL A 288 1 9 SHEET 1 AA1 2 GLY A 52 PRO A 53 0 SHEET 2 AA1 2 SER A 172 CYS A 173 -1 O CYS A 173 N GLY A 52 SHEET 1 AA2 4 LEU A 123 TRP A 125 0 SHEET 2 AA2 4 ASP A 202 ASP A 209 1 O HIS A 205 N LEU A 124 SHEET 3 AA2 4 VAL A 235 ILE A 243 1 O GLU A 239 N VAL A 204 SHEET 4 AA2 4 GLN A 272 ILE A 278 1 O SER A 274 N ALA A 240 SSBOND 1 CYS A 67 CYS A 82 1555 1555 2.04 SSBOND 2 CYS A 99 CYS A 180 1555 1555 1.98 SSBOND 3 CYS A 119 CYS A 201 1555 1555 2.05 SSBOND 4 CYS A 160 CYS A 173 1555 1555 2.03 SSBOND 5 CYS A 254 CYS A 275 1555 1555 2.06 LINK OE2 GLU A 226 C1 HSX A 402 1555 1555 1.43 CRYST1 50.298 64.424 72.832 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019882 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015522 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013730 0.00000